Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,210 total articles
Adobe beat on Q3, raised guidance, and reported accelerating AI monetization, yet the stock trades at a depressed multiple and near-cycle cash generation that argue the worst-case AI outcome is already priced. This trade targets a mid-term rebound while limiting downside with a tight stop.
Saturn Oil's share price has tripled, but the underlying project economics and small-cap valuation still leave room for a disciplined long trade. The set-up works if near-term production and cash generation keep improving and if commodity fundamentals remain supportive. Trade plan included with entry at $1.50, stop at $1.00 and primary/secondary ta…
NRX Pharmaceuticals is a clinical-stage biotech focused on NMDA-platform therapies. With a preservative-free ketamine ANDA advancing toward potential approval, recent commercial preparation and a $20M follow-on raise, and an active short base, NRXP offers a high-risk, high-reward swing trade. Entry at $3.42, target $5.00, stop $2.60 — mid-term hori…
Berkshire Hathaway offers a compelling long trade right now: deep cash reserves, steady free cash flow, aggressive buybacks and a diversified business mix create asymmetric upside with limited downside. We'll lay out an entry, stop and target with time-horizon logic and clear risks.
Devon Energy is trading near $51 with a tidy balance sheet, attractive EV/EBITDA of 7.6x, and recent liability management tied to the Coterra deal. With oil prices likely to stay supportive and integration risk receding after a successful note exchange, this is a mid‑term long idea targeting $60 with a clear stop at $46.50.
Lifecore is a small-cap CDMO with proven hyaluronan capabilities and fresh commercial site transfers that can reaccelerate revenue. The balance sheet and recent guidance cut are real concerns, but the stock's valuation, contract pipeline and elevated short interest create an asymmetric trade for disciplined, risk-aware buyers.
T1 Energy's G2_Austin project is scheduled to materially ramp production and lower unit costs starting in 2027. If the build stays on schedule and commissioning delivers modeled throughput, the company should see a step-change in free cash flow that the market has not fully priced. This is a directional long trade with a measured stop and a multi-m…
Inhibrx (INBX) is a clinical-stage biotech with two near-term, high-impact catalysts: a PDUFA action date for ozekibart (INBRX-109) in April 2027 and Phase 2 PFS data for INBRX-106 expected in Q4 2026. The balance sheet ($161.7M cash after a $75M debt raise), improving operating losses and a market cap near $1.56B create an asymmetric risk/reward f…
Sandisk ($SNDK) is a high-quality NAND flash supplier trading near $1,546. The structural supply/demand story for NAND, recent industry commentary and bullish technicals create a favorable risk/reward for a mid-term long. This trade uses a precise entry, a disciplined stop and a realistic target tied to industry catalysts over the next 45 trading d…
Oracle is trading near $144 after a steep decline from last year's $329 high, while its cloud business and remaining performance obligations have exploded. This trade idea lays out a disciplined long: entry at $144.50, a protective stop at $125.00 and a target at $220.00, with time horizons and risk controls tied to capital intensity, customer conc…
MKS opened a 350,000 sq ft Supercenter in Penang and is expanding capacity in Guangzhou while analysts lift estimates. The stock has pulled back and presents a mid-term swing trade: enter at $245, target $320, stop $210. The plan captures a likely re-rating as factory-related revenue and bookings show through, while protecting against execution or …
WaterBridge Infrastructure (WBI) is a service-grounded infrastructure play with strong reported margins and a concentrated footprint across high-return U.S. shale basins. The stock sits near $32.50, offering a tradeable setup: buy on a disciplined entry, target a re-test of the 52-week high and multiple expansion, and protect capital against execut…
Ampco-Pittsburgh is a compact industrial play with two businesses - forged and cast engineered products and air & liquid processing. At roughly $160M market cap and an enterprise value near $298M, the stock sits well below its 52-week high after a volatile year. Recent contract wins at a subsidiary, elevated short interest and attractive EV/sales c…
Apple's new iPhone Duo is positioned as a meaningful premium upgrade that can add high-margin revenue, accelerate the replacement cycle, and boost Services monetization. We lay out a tactical long with entry at $195.00, target $230.00 and stop at $175.00, horizon focused on the next 45 to 180 trading days depending on catalyst realization.
Sonida Senior Living is shaping up for the next growth phase after closing its $1.8 billion acquisition of CNL Healthcare Properties. Revenue and occupancy have meaningfully improved, institutional ownership has jumped, and the stock sits below recent highs. The setup is actionable: a long at $39.50 with a $50 target and a $34 stop, horizon 180 tra…
Ormat's 1,835 MW operational portfolio, recent $989.5M revenue run-rate and a string of commercial wins (including a 150 MW Google-linked PPA) support a tactical long. Current technical oversold conditions, manageable float (~61.5M shares) and concentrated development optionality from Ormega100 and EGS deployments argue for upside into a re-rating.…
Cytokinetics' Myqorzo (aficamten) is an important commercial proof point, but slow early uptake, minimal revenue, and a valuation that implies blockbuster sales make the stock vulnerable to downside if growth disappoints. I lay out a mid-term short trade with clear entry, stop and target and explain the catalysts, valuation disconnects and risks th…
Arista’s financials look pristine on the surface: high margins, healthy cash flow and AI-driven revenue growth. But that strength is already priced at a premium (market cap ~$239B, P/E ~63, EV/Sales ~23.7) while white-box suppliers and contract manufacturers are pressuring pricing and share in cloud data centers. For traders, a short-on-strength in…
HP is trading like a legacy printer vendor while quietly executing on higher-margin PCs, AI-capable devices and a durable cash-flow profile. Valuation is attractive versus cash-flow and earnings, and recent product launches + enterprise refresh cycles give a clear near-term runway. This is a mid-term swing trade: buy on strength at $35.47 with a $3…
Genworth's mortgage-insurance arm, Enact, is producing strong cash that the parent can use for buybacks and balance-sheet repair. At ~0.45x book and free cash flow of $430M, GNW offers asymmetric upside into $12 while downside is limited by a clean balance sheet and improving earnings.
Adobe reported a clean Q3 beat and is re-prioritizing user acquisition via freemium and agentic AI investment. Management deliberately traded some near-term ARR/margin for scale in AI-first products. The market sold off earlier on that strategy; the Q3 print and raised guidance justify a mid-term swing long with defined risk controls.
Enel Chile (ENIC) trades at a modest multiple with a 3.7% yield, solid profitability and an asset base squarely in the path of Chile's decarbonization. The company's low P/E (10.8) and PB (1.14), combined with steady distribution and improving short-interest dynamics, create an asymmetric risk/reward for a long trade over the next 180 trading days.
AAON (AAON) is a niche leader in commercial and data-center HVAC. At $79.76 the stock trades at ~41x trailing earnings; I see a path to meaningful EPS growth driven by data-center demand and domestic manufacturing tailwinds that could make a 23x multiple on 2027 earnings reasonable. This trade idea lays out an entry, stop and target with horizon an…
Marathon Petroleum (MPC) looks positioned to capture continued upside as tight refined‑product markets and elevated crack spreads sustain unusually strong refining profits. The company’s Q2 outperformance, large free cash flow generation and capital returns give a favorable risk/reward for a disciplined long trade sized to a 180 trading‑day horizon…
Dutch Bros has seen a meaningful multiple contraction despite continued top-line momentum and a large expansion runway. Technical oversold conditions, elevated short interest, and a pullback from the $74 cycle high create an actionable long trade with clear entry, stop and multi-horizon targets.
